RHO Stereopure Antisense Oligonucleotide Therapy (Wave Life Sciences)

N/A

Report date: 2025/01/26 19:29:36
NME

Base Information

Drug NameRHO Stereopure Antisense Oligonucleotide Therapy (Wave Life Sciences)
Drug Alias NameRHO Gene Inhibitor (Wave Life Sciences)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRhodopsin inhibitors
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWave Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWave Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A